CN Patent

CN109206417B — 阿片受体激动剂及其应用

Assigned to Tibet Haisike Pharmaceutical Co ltd · Expires 2023-01-03 · 3y expired

What this patent protects

本申请描述了可以用作阿片受体配体的化合物及其盐,及制备方法和含有该化合物的组合物,及其可以作为μ阿片受体激动剂的用途,用于治疗μ阿片受体介导的相关疾病,如疼痛和疼痛相关的紊乱。

USPTO Abstract

本申请描述了可以用作阿片受体配体的化合物及其盐,及制备方法和含有该化合物的组合物,及其可以作为μ阿片受体激动剂的用途,用于治疗μ阿片受体介导的相关疾病,如疼痛和疼痛相关的紊乱。

Drugs covered by this patent

Patent Metadata

Patent number
CN109206417B
Jurisdiction
CN
Classification
Expires
2023-01-03
Drug substance claim
No
Drug product claim
No
Assignee
Tibet Haisike Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.